Abstract
Our objective is to investigate the relationship between drug and
menstrual cycle symptoms in HIV+ women receiving antiretroviral
therapy (HAART). Interviews were done for 12 weeks with 54 HIV+
women receiving HAART. Patients were asked if they experienced
any of 28 symptoms associated with HAART and the menstrual cycle
and about HAART adherence. Weeks were divided into menstrual weeks
(MWs), premenstrual weeks (PWs), and other weeks. Women reported
more bloating (